Editorial: Molecular Diagnostics of Pediatric Cancer, Volume II
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Irwin M, Goldsmith K
. Current and Emerging Biomarkers: Impact on Risk Stratification for Neuroblastoma. J Natl Compr Canc Netw. 2024; 22(6).
DOI: 10.6004/jnccn.2024.7051.
View
2.
Sweet-Cordero E, Biegel J
. The genomic landscape of pediatric cancers: Implications for diagnosis and treatment. Science. 2019; 363(6432):1170-1175.
PMC: 7757338.
DOI: 10.1126/science.aaw3535.
View
3.
Carli D, Kalantari S, Manicone R, Coppo P, Francia di Celle P, La Selva R
. Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum. Clin Genet. 2021; 100(5):624-627.
DOI: 10.1111/cge.14047.
View
4.
Zhang J, Walsh M, Wu G, Edmonson M, Gruber T, Easton J
. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015; 373(24):2336-2346.
PMC: 4734119.
DOI: 10.1056/NEJMoa1508054.
View
5.
Brodeur G, Nichols K, Plon S, Schiffman J, Malkin D
. Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr. Clin Cancer Res. 2017; 23(11):e1-e5.
PMC: 5553563.
DOI: 10.1158/1078-0432.CCR-17-0702.
View